Startups

Breethe, Inc. is making an artificial lung for patients to take home from the hospital

It's said to be the world's first “out-of-hospital” artificial lung. The University of Maryland's commercialization arm is backing the venture.

Dr. Bartley Griffith, surgeon and founder of Breethe, Inc. (Photo courtesy of University of Maryland School of Medicine)

A University of Maryland School of Medicine researcher found a way for patients to take an artificial lung with them when they leave the hospital. In addition to taking pride in the research developed at the Baltimore-based campus, the university also sees business potential.
The “out-of-hospital” artificial lung, developed by Dr. Bartley Griffith, is at the heart of a University of Maryland BioPark-based startup called Breethe, Inc.
This week, University of Maryland’s commercialization arm announced a deal to license the technology to Breethe. UM Ventures is also investing $100,000, marking the second such financial backing the university has made to a company that started with university research. The investment was part of a seed round that the company closed in January.
Griffith is already a distinguished surgeon in heart and transplant surgery. With the new technology, he became a startup founder.
The device is thought to be the first wearable artificial lung that can be taken out of the hospital. In a statement, Griffith said there is a growing demand in the healthcare industry for technology that allows patients to be mobile.
“This is a device that could potentially take patients that are right now hospital-bound and ventilated, and let them leave the hospital and let them resume a fairly normal function,” said UM Ventures Chief Commercialization Officer Phil Robilotto.

Companies: University of Maryland, Baltimore / University of Maryland BioPark
Subscribe

Knowledge is power!

Subscribe for free today and stay up to date with news and tips you need to grow your career and connect with our vibrant tech community.

Technically Media